Erratum to: Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus

[1]  T. Hawn,et al.  Emerging Infectious Diseases , 2011, Berkowitz’s Pediatrics: A Primary Care Approach.

[2]  F. Uckun,et al.  Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. , 2004, European journal of medicinal chemistry.

[3]  S. Günther,et al.  Imported Lassa fever in Germany: surveillance and management of contact persons. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Uckun,et al.  Toxicity and Pharmacokinetics of Stampidine in Mice and Rats , 2003, Arzneimittelforschung.

[5]  D. Richman,et al.  Stampidine Is a Potent Inhibitor of Zidovudine- and Nucleoside Analog Reverse Transcriptase Inhibitor-Resistant Primary Clinical Human Immunodeficiency Virus Type 1 Isolates with Thymidine Analog Mutations , 2002, Antimicrobial Agents and Chemotherapy.

[6]  F. Uckun,et al.  In Vivo Toxicity, Pharmacokinetics, and Anti-Human Immunodeficiency Virus Activity of Stavudine-5′-(p-Bromophenyl Methoxyalaninyl Phosphate) (Stampidine) in Mice , 2002, Antimicrobial Agents and Chemotherapy.

[7]  O. Ramilo,et al.  Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. , 2002, The Journal of pediatrics.

[8]  M. Tardieu,et al.  HIV-1 and the central nervous system. , 2002, Current topics in microbiology and immunology.

[9]  A. Hoerauf,et al.  Monitoring of clinical and laboratory data in two cases of imported Lassa fever. , 2002, Microbes and infection.

[10]  H. Adle-Biassette,et al.  Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. , 2001, Clinical neuropathology.

[11]  F. Uckun,et al.  In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (SAMPIDINE) in mice. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[12]  L. Hagberg,et al.  Antiretroviral treatment of central nervous system HIV‐1 infection: a review , 2001, HIV medicine.

[13]  C. Power,et al.  Neuroimmune and neurovirological aspects of human immunodeficiency virus infection. , 2001, Advances in virus research.

[14]  J. P. Chen,et al.  Hemorrhagic fever virus-induced changes in hemostasis and vascular biology , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[15]  A. White,et al.  Tropical Infectious Diseases: Principles, Pathogens, and Practice , 2000, Annals of Internal Medicine.

[16]  F. Uckun,et al.  AZT-5′-(p-Bromophenyl Methoxyalaninyl Phosphate) as a Potent and Non-Toxic Anti-Human Immunodeficiency Virus Agent , 1999, Antiviral chemistry & chemotherapy.

[17]  F. Uckun,et al.  Enhancing effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of d4T-phenyl methoxyalaninyl phosphate derivatives. , 1998, Bioorganic & medicinal chemistry letters.

[18]  F. Uckun,et al.  D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent. , 1998, Antiviral chemistry & chemotherapy.

[19]  C. Peters,et al.  The phylogeny of New World (Tacaribe complex) arenaviruses. , 1996, Virology.

[20]  Lianguo Wang,et al.  In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. , 1996, Journal of medicinal chemistry.

[21]  Ignat'ev Gm,et al.  [Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus]. , 1994 .

[22]  R. Rico-Hesse,et al.  New arenavirus isolated in Brazil , 1994, The Lancet.

[23]  L. Pereboeva,et al.  [Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus]. , 1994, Voprosy virusologii.

[24]  R. Rico-Hesse,et al.  Venezuelan haemorrhagic fever , 1991, The Lancet.

[25]  L. Brammer,et al.  Lassa fever in the United States. Investigation of a case and new guidelines for management. , 1990, The New England journal of medicine.

[26]  I. Lukashevich,et al.  [The cultivation and physicochemical properties of the Josiah strain of the Lassa virus]. , 1990, Voprosy virusologii.

[27]  M. S. Mahdy,et al.  Lassa fever: the first confirmed case imported into Canada. , 1989, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

[28]  S. Oka,et al.  [The first imported case of Lassa fever in Japan]. , 1989, Nihon rinsho. Japanese journal of clinical medicine.

[29]  E. Sikuler,et al.  [Lassa fever--first case diagnosed in Israel]. , 1988, Harefuah.

[30]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[31]  P. Jahrling,et al.  Pediatric Lassa fever: a review of 33 Liberian cases. , 1987, The American journal of tropical medicine and hygiene.

[32]  J. McCormick,et al.  Lassa virus hepatitis: a study of fatal Lassa fever in humans. , 1986, The American journal of tropical medicine and hygiene.

[33]  J. McCormick,et al.  Lassa fever in children in Sierra Leone, West Africa. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  P. Jahrling,et al.  Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  A. Fabiyi.  Lassa fever (arenaviruses) as a public health problem. , 1976, Bulletin of the Pan American Health Organization.

[36]  T. Monath.  Lassa fever: review of epidemiology and epizootiology. , 1975, Bulletin of the World Health Organization.

[37]  J. Frame.  Surveillance of Lassa fever in missionaries stationed in West Africa. , 1975, Bulletin of the World Health Organization.

[38]  T. Monath,et al.  Lassa fever: review of epidemiology and epizootiology. , 1975, Bulletin of the World Health Organization.

[39]  J. Frame,et al.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.

[40]  H. Bourne,et al.  Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. , 1970, The American journal of tropical medicine and hygiene.

[41]  J. Casals,et al.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. , 1970, The American journal of tropical medicine and hygiene.

[42]  A. Shelokov,et al.  Virus Isolations from Human Cases of Hemorrhagic Fever in Bolivia , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  N. Mettler,et al.  [Concerning the epidemic outbreak in Junin]. , 1958, El Dia medico.

[44]  R. Lillie,et al.  Experimental Lymphocytic Choriomeningitis of Monkeys and Mice Produced by a Virus Encountered in Studies of the 1933 St. Louis Encephalitis Epidemic , 1934 .